| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,819,000 | 1,979,000 | 2,535,000 | 2,640,000 | | Cost of Revenue | 1,403,000 | 1,581,000 | 1,884,000 | 1,941,000 | | | Gross Profit | 416,000 | 398,000 | 651,000 | 699,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 423,000 | 422,000 | 461,000 | 484,000 | | Non Recurring |
-
| 467,000 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (7,000) | (491,000) | 190,000 | 215,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,000) | (32,000) | 2,000 | 1,000 | | Earnings Before Interest And Taxes | (10,000) | (523,000) | 192,000 | 216,000 | | Interest Expense | 56,000 | 56,000 | 59,000 | 57,000 | | Income Before Tax | (66,000) | (579,000) | 133,000 | 159,000 | | Income Tax Expense | 8,000 | (75,000) | 92,000 | 75,000 | | Minority Interest |
-
| (4,000) | (11,000) | (12,000) | | | | Net Income From Continuing Ops | (74,000) | (508,000) | 30,000 | 72,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 3,000 | 10,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (74,000) | (508,000) | 33,000 | 82,000 | | Preferred Stock And Other Adjustments | (7,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($81,000) | ($508,000) | $33,000 | $82,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
